A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

Trial Profile

A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Decitabine (Primary) ; Vorinostat (Primary) ; Dexamethasone; Methotrexate; Mitoxantrone; Pegaspargase; Vincristine
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
    • 15 Sep 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 12 Mar 2013 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top